Weekly Recap: Fresenius share sale and Barclays downgrades FME
Moins d'1 minute de lecture
Fresenius Medical Care AG Sponsored ADR (XETR:FME) reported that Fresenius sold 13.4 million shares at €39 each, raising about €524 million and cutting its stake from 25% to 20%. Barclays downgraded the company to Underweight from Equal-Weight.
Previous Week Recap
- Fresenius Raises €524 Million: Fresenius sold 13.4 million FME shares at €39 each, raising about €524 million and cutting its stake from 25% to 20%. Investor demand exceeded the offer; remaining shares face a 90-day lock-up. 3 sources
- Barclays Downgrades FME To Underweight: Barclays downgraded Fresenius Medical Care AG Sponsored ADR (FME) to Underweight from Equal-Weight. TradingView
- Goldman Sachs Voting-Threshold Disclosure: Fresenius Medical Care (FME) said Goldman Sachs crossed a voting-rights disclosure threshold around Nov. 3–4, 2026. The filing gave no resulting stake; a major holdings notice was issued Nov. 10. 2 sources
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.